Epstein-Barr virus infection
MONDO:0005111An infection that is caused by Epstein-Barr virus.
Also known as: EBV infection, Epstein-Barr Virus infection, Human gammaherpesvirus 4 caused disease or disorder, Human gammaherpesvirus 4 disease or disorder, Human gammaherpesvirus 4 infectious disease, EBV infections, Epstein Barr Virus infections, Herpesvirus 4 infections, Human
63 clinical trials for this condition and its sub-types, 61 tagged with Epstein-Barr virus infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Epstein-Barr virus infection
-
Infectious mononucleosis 8 trials
-
Epstein-Barr virus hepatitis 0 trials
-
New mRNA vaccine targets Epstein-Barr virus in first human trial
Vaccine Not yet recruitingThis early-stage trial is testing a new mRNA vaccine called VXCO-102 against Epstein-Barr virus (EBV) in 45 healthy adults aged 18 to 25. The main goal is to check if the vaccine is safe and triggers an immune response. EBV is a common virus that can cause mononucleosis and is li…
Phase 1 • Sponsor: Vaccine Company, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:25 UTC
-
New antibody shows promise against Post-Transplant virus threat
Disease control Not yet recruitingThis phase 2 trial tests a new drug called zuberitamab as a first-line treatment for EBV infection in 20 adults who have had a stem cell transplant. EBV can cause a serious complication after transplant, and current treatments don't work for everyone. Zuberitamab is designed to b…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a cancer drug stop a deadly complication in transplant patients?
Prevention Not yet recruitingThis study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…
Phase 1 • Sponsor: Jennifer Amengual • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Donor t cells aim to block virus after transplant
Prevention Not yet recruitingThis early-stage study tests whether specially prepared immune cells from a donor can prevent Epstein-Barr virus (EBV) infection in people who have received a stem cell transplant. About 9 to 18 participants will receive the cells and be monitored for side effects and infection. …
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC